TY  - GEN
AU  - Garcia-Doval,Ignacio
AU  - Carretero,Gregorio
AU  - Vanaclocha,Francisco
AU  - Ferrandiz,Carlos
AU  - Daudén,Esteban
AU  - Sánchez-Carazo,Jose-Luis
AU  - Alsina,Mercé
AU  - Herrera-Ceballos,Enrique
AU  - Gómez-García,Francisco-José
AU  - Ferrán,Marta
AU  - López-Estebaranz,Jose-Luis
AU  - Hernanz,Jose-Manuel
AU  - Belinchón-Romero,Isabel
AU  - Vilar-Alejo,Jaime
AU  - Rivera,Raquel
AU  - Carrascosa,Jose-Manuel
AU  - Carazo,Cristina
TI  - Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials
SN  - 1538-3652
PY  - 2012///0604
KW  - Adult
KW  - Age Factors
KW  - Aged
KW  - Anti-Inflammatory Agents
KW  - adverse effects
KW  - Antibodies, Monoclonal
KW  - Biological Products
KW  - Female
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Keratolytic Agents
KW  - Male
KW  - Middle Aged
KW  - PUVA Therapy
KW  - Patient Selection
KW  - Proportional Hazards Models
KW  - Psoriasis
KW  - classification
KW  - Randomized Controlled Trials as Topic
KW  - Risk Assessment
KW  - Spain
N1  - Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1001/archdermatol.2011.2768
ER  -